A major priority for the addiction treatment field is the development of medications for the treatment of cocaine abuse and dependence. An obstacle to the development of such medications is the lengthy duration necessary to conduct clinical trials. This project proposes a methodology which can rapidly and efficiently screen medications for their benefits as pharmacotherapies for cocaine treatment. The study will make use of two research sites which have a successful history of recruiting large numbers of subjects into addiction pharmacotherapy trials. The Matrix Center West Los Angeles Clinic will provide 350 primary cocaine abusers for the study of five potentially beneficial medications. The Pizarro Treatment Center will provide 280 primary opiate addicts maintained on opiate maintenance pharmacotherapy who have a diagnosis of cocaine abuse or dependence. Four medications will be studied at this site. Each medication will be assessed under double-blind conditions, using a standardized psychosocial protocol, with standardized induction measures. Each medication will be evaluated over a 16 week period with 70 subjects per study (35 medication, 35 placebo). Through the use of this rapid screening methodology, the efficiency of identifying useful medications for cocaine abuse treatment will be significantly improved.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA009260-04
Application #
6238016
Study Section
Project Start
1997-09-01
Project End
1998-07-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Friends Research Institute, Inc.
Department
Type
DUNS #
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Miotto, Karen; Hillhouse, Maureen; Donovick, Roger et al. (2012) Comparison of buprenorphine treatment for opioid dependence in 3 settings. J Addict Med 6:68-76
Ling, Walter; Cunningham-Rathner, Jerry; Rawson, Richard (2004) Diffusion of substance abuse treatment: will buprenorphine be a success? J Psychoactive Drugs Suppl 2:115-7
Ling, Walter; Wesson, Donald R (2003) Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Drug Alcohol Depend 70:S49-57
Lopatko, Olga V; White, Jason M; Huber, Alice et al. (2003) Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine. Drug Alcohol Depend 69:317-22
Ling, Walter; Rawson, Richard A; Compton, Margaret (2003) Clinical treatment of opioid addiction and dependence. Methods Mol Med 84:285-95
Doverty, M; White, J M; Somogyi, A A et al. (2001) Hyperalgesic responses in methadone maintenance patients. Pain 90:91-6
Doverty, M; Somogyi, A A; White, J M et al. (2001) Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain 93:155-63
Kirkish, P; Sreenivasan, S; Welsh, R et al. (2000) The future of criminal violence: juveniles tried as adults. J Am Acad Psychiatry Law 28:38-46
Ling, W; Shoptaw, S; Majewska, D (1998) Baclofen as a cocaine anti-craving medication: a preliminary clinical study. Neuropsychopharmacology 18:403-4
Frosch, D L; Shoptaw, S; Jarvik, M E et al. (1998) Interest in smoking cessation among methadone maintained outpatients. J Addict Dis 17:9-19

Showing the most recent 10 out of 12 publications